Next Article in Journal
Effect of Pyruvate Decarboxylase Knockout on Product Distribution Using Pichia pastoris (Komagataella phaffii) Engineered for Lactic Acid Production
Previous Article in Journal
Theoretical Insight into the Biodegradation of Solitary Oil Microdroplets Moving through a Water Column
Article Menu
Issue 1 (March) cover image

Export Article

Open AccessArticle
Bioengineering 2018, 5(1), 16;

Fenofibrate Nanocrystals Embedded in Oral Strip-Films for Bioavailability Enhancement

Department of Chemical, Biological and Pharmaceutical Engineering, New Jersey Institute of Technology, Newark, NJ 07102, USA
Department of Pharmacology, Government Medical College, Bhavnagar 364002, Gujarat, India
Analytical Discipline and Centralized Instrument Facility, The Academy of Scientific & Innovative Research (AcSIR), Central Salt and Marine Chemicals Research Institute, Council of Scientific and Industrial Research (CSIR), G.B. Marg, Bhavnagar 364002, Gujarat, India
Present address: Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Author to whom correspondence should be addressed.
Received: 29 December 2017 / Revised: 4 February 2018 / Accepted: 7 February 2018 / Published: 13 February 2018
Full-Text   |   PDF [9438 KB, uploaded 13 February 2018]   |  


The aim of the present study was to make a fenofibrate (FNB) nanocrystal (NC) by wet media milling, characterizations and formulates into oral strip-films (OSFs). Mechanical properties, redispersion study, and solid-state characterizations results suggested that reduction of drug crystal size at nanoscale and incorporation into OSFs does not affect the solid-state properties of the drug. In vitro dissolution kinetics showed enhanced dissolution rate was easily manipulated by changing the thickness of the OSF. In situ UV-imaging was used to monitor drug dissolution qualitatively and quantitatively in real time. Results confirm that the intrinsic dissolution rates and surface drug concentration measured with this device were in agreement with the USP-IV dissolution profiles. In vivo pharmacokinetics in rabbits showed a significant difference in the pharmacokinetics parameter (1.4 fold increase bioavailability) of FNB NC-loaded OSFs as compared to the marketed formulation “Tricor” and as-received (pristine) drug. This approach of drug nanocrystallization and incorporation into OSFs may have significant applications in cost-effective tools for bioavailability enhancement of FNB. View Full-Text
Keywords: bioavailability; fenofibrate; media milling; pharmacokinetics; UV imaging bioavailability; fenofibrate; media milling; pharmacokinetics; UV imaging

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Kevadiya, B.D.; Barvaliya, M.; Zhang, L.; Anovadiya, A.; Brahmbhatt, H.; Paul, P.; Tripathi, C. Fenofibrate Nanocrystals Embedded in Oral Strip-Films for Bioavailability Enhancement. Bioengineering 2018, 5, 16.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Bioengineering EISSN 2306-5354 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top